112 related articles for article (PubMed ID: 9013212)
1. Beta-adrenergic receptor and platelet inhibitory activities of a new series of trimetoquinol and related benzazepine analogs.
Shams G; Romstedt KJ; Lust LA; Clark MT; Miller DD; Feller DR
Gen Pharmacol; 1997 Feb; 28(2):323-30. PubMed ID: 9013212
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological evaluation of the beta-adrenoceptor agonist and thromboxane receptor blocking properties of 1-benzyl substituted trimetoquinol analogues.
Shams G; Romstedt KJ; Gerhardt MA; Harrold MW; Miller DD; Feller DR
Eur J Pharmacol; 1990 Aug; 184(1):21-31. PubMed ID: 1976530
[TBL] [Abstract][Full Text] [Related]
3. Halogen-substituted trimetoquinol analogs as thromboxane A2 receptor antagonists in platelets and aorta.
Romstedt KJ; Shin Y; Shams G; Doyle K; Tantishaiyakul V; Clark MT; Adejare A; Hamada A; Miller DD; Feller DR
Biochem Pharmacol; 1993 Dec; 46(11):2051-9. PubMed ID: 8267653
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological evaluation of the beta-adrenoceptor agonist and thromboxane antagonist properties of N-substituted trimetoquinol analogues.
Fedyna JS; Adejare A; Miller DD; Feller DR
Eur J Pharmacol; 1987 Mar; 135(2):161-71. PubMed ID: 2884118
[TBL] [Abstract][Full Text] [Related]
5. Effect of trimetoquinol analogs for antagonism of endoperoxide/thromboxane A2-mediated responses in human platelets and rat aorta.
Mukhopadhyay A; Navran SS; Amin HM; Abdel-Aziz SA; Chang J; Sober DJ; Miller DD; Feller DR
J Pharmacol Exp Ther; 1985 Jan; 232(1):1-9. PubMed ID: 3855323
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological properties of novel bicyclic isoquinoline analogs in isolated guinea pig atria, trachea and in human platelets: relationship to trimetoquinol.
Shams G; Fedyna J; Romstedt KJ; Adejare A; Miller DD; Roche VF; Feller DR
Gen Pharmacol; 1991; 22(6):1155-63. PubMed ID: 1687397
[TBL] [Abstract][Full Text] [Related]
7. Interactions of nonprostanoid trimetoquinol analogs with thromboxane A2/prostaglandin H2 receptors in human platelets, rat vascular endothelial cells and rat vascular smooth muscle cells.
Shin Y; Romstedt KJ; Miller DD; Feller DR
J Pharmacol Exp Ther; 1993 Dec; 267(3):1017-23. PubMed ID: 7903383
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological characterization of cinnamophilin, a novel dual inhibitor of thromboxane synthase and thromboxane A2 receptor.
Yu SM; Wu TS; Teng CM
Br J Pharmacol; 1994 Mar; 111(3):906-12. PubMed ID: 8019768
[TBL] [Abstract][Full Text] [Related]
9. Syntheses and beta-adrenergic agonist and antiaggregatory properties of N-substituted trimetoquinol analogues.
Adejare A; Miller DD; Fedyna JS; Ahn CH; Feller DR
J Med Chem; 1986 Sep; 29(9):1603-9. PubMed ID: 2875182
[TBL] [Abstract][Full Text] [Related]
10. Pharmacologic antagonism of thromboxane A2 receptors by trimetoquinol analogs in vitro and in vivo.
Shin Y; Romstedt KJ; Doyle K; Harrold MW; Gerhardt MA; Miller DD; Patil PN; Feller DR
Chirality; 1991; 3(2):112-7. PubMed ID: 1830752
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the inhibition of U46619-mediated human platelet activation by the trimetoquinol isomers. Evidence for endoperoxide/thromboxane A2 receptor blockade.
Ahn CH; Romstedt KJ; Wallace LJ; Miller DD; Feller DR
Biochem Pharmacol; 1988 Aug; 37(15):3023-33. PubMed ID: 3134894
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of halogenated trimetoquinol derivatives and evaluation of their beta-agonist and thromboxane A2 (TXA2) antagonist activities.
Markovich KM; Tantishaiyakul V; Hamada A; Miller DD; Romstedt KJ; Shams G; Shin Y; Fraundorfer PF; Doyle K; Feller DR
J Med Chem; 1992 Feb; 35(3):466-79. PubMed ID: 1346651
[TBL] [Abstract][Full Text] [Related]
13. Heterogeneity of thromboxane A2 (TP-) receptors: evidence from antagonist but not agonist potency measurements.
Tymkewycz PM; Jones RL; Wilson NH; Marr CG
Br J Pharmacol; 1991 Mar; 102(3):607-14. PubMed ID: 1364826
[TBL] [Abstract][Full Text] [Related]
14. Effects of thromboxane A2 on thoracic aorta of young and old rats: use of selective thromboxane receptor antagonists.
Shams G; Wallace LJ; Miller DD; Feller DR
Pharmacology; 1990; 40(1):27-32. PubMed ID: 2139513
[TBL] [Abstract][Full Text] [Related]
15. Evidence for human thromboxane receptor heterogeneity using a novel series of 9,11-cyclic carbonate derivatives of prostaglandin F2 alpha.
Krauss AH; Woodward DF; Gibson LL; Protzman CE; Williams LS; Burk RM; Gac TS; Roof MB; Abbas F; Marshall K; Senior J
Br J Pharmacol; 1996 Mar; 117(6):1171-80. PubMed ID: 8882612
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological evidence for thromboxane receptor heterogeneity--implications for the eye.
Krauss AH; Woodward DF; Burk RM; Gac TS; Gibson LL; Protzman CE; Abbass F; Marshall K; Senior J
J Ocul Pharmacol Ther; 1997 Aug; 13(4):303-12. PubMed ID: 9261766
[TBL] [Abstract][Full Text] [Related]
17. Cinnamophilin, a novel thromboxane A2 receptor antagonist, isolated from Cinnamomum philippinense.
Yu SM; Ko FN; Wu TS; Lee JY; Teng CM
Eur J Pharmacol; 1994 Apr; 256(1):85-91. PubMed ID: 8026563
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological activities of trimetoquinol and 1-benzyl halogen-substituted analogues on rat beta-adrenoceptor subtypes.
Konkar AA; Fraundorfer PF; Fertel RH; Burkman AM; Miller DD; Feller DR
Eur J Pharmacol; 1996 Jun; 305(1-3):63-71. PubMed ID: 8813533
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and platelet antiaggregatory activity of trimetoquinol analogs as endoperoxide/thromboxane A2 antagonists.
Harrold MW; Gerhardt MA; Romstedt K; Feller DR; Miller DD
Drug Des Deliv; 1987 Feb; 1(3):193-207. PubMed ID: 3509333
[TBL] [Abstract][Full Text] [Related]
20. Antiaggregant and antivasospastic properties of the new thromboxane A2 receptor antagonist sodium 4-[[1-[[[(4-chlorophenyl)sulfonyl]amino]methyl]cyclopentyl] methyl]benzeneacetate.
Lardy C; Rousselot C; Chavernac G; Depin JC; Guerrier D
Arzneimittelforschung; 1994 Nov; 44(11):1196-202. PubMed ID: 7848331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
